UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000027603 |
|---|---|
| Receipt number | R000031569 |
| Scientific Title | Clinicopathological analysis of 5-year survivors of glioblastoma -Multiinstitutional retrospective study- |
| Date of disclosure of the study information | 2017/06/03 |
| Last modified on | 2026/06/14 15:01:55 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Clinicopathological analysis of 5-year survivors of glioblastoma -Multiinstitutional retrospective study-
Acronym
Clinicopathological analysis of 5-year survivors of glioblastoma -Multiinstitutional retrospective study-
Scientific Title
Clinicopathological analysis of 5-year survivors of glioblastoma -Multiinstitutional retrospective study-
Scientific Title:Acronym
Clinicopathological analysis of 5-year survivors of glioblastoma -Multiinstitutional retrospective study-
Region
| Japan |
Condition
Condition
Glioblastoma
Classification by specialty
| Neurosurgery |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To evaluate the clinico-pathological features of long term (>5 years) survivors in glioblastoma patients
Basic objectives2
Others
Basic objectives -Others
Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Clinical data, Radiological findings, Pathological diagnosis
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Survival>5 years
Key exclusion criteria
Not applicable
Target sample size
22
Research contact person
Name of lead principal investigator
| 1st name | Takamitsu |
| Middle name | |
| Last name | Fujimaki |
Organization
Saitama Medical University
Division name
Department of Neurosurgery
Zip code
391
Address
Morohongo 38, Moroyamamachi, Irumagunn, Saitama Japan
TEL
0492761287
tfujimak@umin.ac.jp
Public contact
Name of contact person
| 1st name | Takamitsu |
| Middle name | |
| Last name | Takamitsu Fujimaki |
Organization
Saitama Medical University
Division name
Department of Neurosurgery
Zip code
350 0495
Address
Morohongo 38, Moroyamamachi, Irumagunn, Saitama Japan
TEL
0492761287
Homepage URL
tfujimak@umin.ac.jp
Sponsor or person
Institute
Others
Institute
Department
Personal name
Funding Source
Organization
Self funding
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Institutional Research Board of Saitama Medical University
Address
Morohongo 38, Moroyamamachi, Irumagunn, Saitama Japan
Tel
0492761287
irb@saitama-med.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2017 | Year | 06 | Month | 03 | Day |
Related information
URL releasing protocol
https://www.saitama-med.ac.jp/hospital/
Publication of results
Unpublished
Result
URL related to results and publications
https://www.saitama-med.ac.jp/hospital/
Number of participants that the trial has enrolled
22
Results
The followings were pointed out to be long-term survival factors for glioblastoma,
1.young age of onset
2.favorable PS
3.localization to frontal lobe
Results date posted
| 2026 | Year | 06 | Month | 14 | Day |
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
N/A
Participant flow
N/A
Adverse events
None
Outcome measures
N/A
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
No longer recruiting
Date of protocol fixation
| 2016 | Year | 05 | Month | 20 | Day |
Date of IRB
| 2016 | Year | 05 | Month | 20 | Day |
Anticipated trial start date
| 2016 | Year | 05 | Month | 20 | Day |
Last follow-up date
| 2017 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
| 2017 | Year | 03 | Month | 31 | Day |
Date trial data considered complete
| 2017 | Year | 03 | Month | 31 | Day |
Date analysis concluded
| 2017 | Year | 03 | Month | 31 | Day |
Other
Other related information
None
Management information
Registered date
| 2017 | Year | 06 | Month | 02 | Day |
Last modified on
| 2026 | Year | 06 | Month | 14 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000031569
